medigraphic.com
ISSN 1684-1824 (Digital)

2021, Número 5

<< Anterior Siguiente >>

Rev Méd Electrón 2021; 43 (5)


Desórdenes del metabolismo glucídico y síndrome metabólico en pacientes de covid-19

Rufín GLÁ, Rufín BAM, Martínez MA, Vega SMN

Idioma: Español
Referencias bibliográficas: 47
Paginas: 1-13
Archivo PDF: 1782.73 Kb.


RESUMEN

El síndrome metabólico comprende un conjunto de factores de riesgo cardiovascular asociado a resistencia a la insulina, que propicia la aparición de enfermedad cardiovascular y de diabetes mellitus tipo 2. Su etiología se atribuye a la combinación de factores genéticos y ambientales, asociados al estilo de vida, que favorecen un estado proinflamatorio y protrombótico que empeora el cuadro clínico de los pacientes con covid-19. El objetivo de la revisión consistió en analizar el estado actual del conocimiento científico en las investigaciones sobre la interrelación entre los desórdenes del metabolismo glucídico y el síndrome metabólico, asociados a la condición proinflamatoria exacerbada en pacientes de covid-19. Se hicieron búsquedas en las bases de datos PubMed, SciELO, ClinicalKey y LILACS. Al proceso proinflamatorio generado por malos hábitos alimentarios, la sobrealimentación calórica de alto índice glicémico, y estilos de vida sedentarios, se atribuye un papel relevante en la patogénesis del síndrome metabólico, así como en sus posibles complicaciones en pacientes de covid-19 con comorbilidades asociadas. Es posible reducir la condición inflamatoria del síndrome metabólico mediante modificaciones en el estilo de vida y hábitos alimentarios, que prevengan la obesidad y sus efectos en la resistencia a la insulina, lo cual propicia reducir la gravedad asociada a los procesos inflamatorios inherentes.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. PalR, BhansaliA. COVID-19, diabetes mellitus and ACE2: theconundrum. Diabetes Res ClinPract. 2020;162:108132. Citado en PubMed; PMID: 32234504.

  2. WuZ, McGooganJM. Characteristics of and important lessons from the coronavirus disease (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention. J Am Med Assoc. 2020;323:1239-42. Citado en PubMed; PMID: 32091533.

  3. VerityR, OkellLC, DorigattiI, et al. Estimates of the severity of coronavirus disease (COVID-19): a model-based analysis. Lancet Infect Dis. 2020;20(6):669-77. Citado en PubMed; PMID: 32240634.

  4. GrasselliG, PesentiA, CecconiM. Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: early experience and forecast during an emergency response. JAMA. 2020;323(16):1545-6. Citado en PubMed; PMID: 32167538.

  5. LiuY, YanLM, WanL, et al. Viral dynamics in mild and severe cases of COVID-19. Lancet Infect Dis. 2020;20(6):656-7. Citado en PubMed; PMID:32199493.

  6. LiuK, FangYY, DengY, et al. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. Chin Med J (Engl). 2020;133(9):1025-31. Citado en PubMed; PMID:32044814.

  7. OnderG, RezzaG, BrusaferroS. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA. 2020 May12;323(18):1775-6. Citado en PubMed; PMID:32203977.

  8. LeisegangK, HenkelR, AgarwalA. Obesity and metabolic syndrome associated with systemic inflammation and the impact on the male reproductive system. Am J ReprodImmunol. 2019;82(5):e13178. Citado en PubMed; PMID:31373727.

  9. SherlingDH, PerumareddiP, HennekensCH. Metabolic Syndrome. J CardiovascPharmacolTher.2017;22:365-7. Citado en PubMed; PMID:28587579.

  10. SaklayenMG. The global epidemic of the metabolic syndrome.CurrHypertens Rep.2018;20(2):12. Citado en PubMed; PMID:29480368.

  11. GrundySM. Metabolic syndrome update. Trends in Cardiovascular Medicine.2016;26(4):364-73. Citado en PubMed; PMID:26654259.

  12. AnJ, YoonSR, LeeJH, et al. Importance of Adherence to Personalized Diet Intervention in Obesity Related Metabolic Improvement in Overweight and Obese Korean Adults. ClinNutr Res. 2019;8(3):171-83. Citado en PubMed; PMID:31384596.

  13. MazidiM, PennathurS, AfshinniaF. Link of dietary patterns with metabolic syndrome: analysis of the National Health and Nutrition Examination Survey. Nutr Diabetes. 2017;7(3):e255. Citado en PubMed; PMID:28319105.

  14. LiY, ZhaoL, YuD, et al. Metabolic syndrome prevalence and its risk factors among adults in China: A nationally representative cross-sectional study. PLoSOne. 2018;13(6):e0199293. Citado en PubMed; PMID:29920555.

  15. BahariT, UemuraH, Katsuura-KamanoS, et al. Nutrient-derived dietary patterns and their association with metabolic syndrome in a Japanese population.J Epidemiol. 2018;28(4):194-201. Citado en PubMed; PMID:29151477.

  16. LeeYJ, SongS, SongY. High-carbohydrate diets and food patterns and their associations with metabolic disease in the Korean population. Yonsei Med J. 2018;59(7):834-42. Citado en PubMed; PMID:6082982.

  17. VosMB. Added sugars and cardiovascular disease risk in children: a scientific statement from the American Heart Association. Circulation. 2017;135(19):e1017-34. Citado en PubMed; PMID: 5408160.

  18. SuligaE, CieślaE, RębakD, et al. Relationship Between Sitting Time, Physical Activity, and Metabolic Syndrome Among Adults Depending on Body Mass Index (BMI). MedSciMonit. 2018 Oct 26;24:7633-45. Citado en PubMed; PMID: 30361469.

  19. Cardellá RosalesL, HernándezR. Carbohidratos en la dieta humana. En: Cardellá RosalesLL, Hernández FernándezRA, Pita RodríguezGM. Metabolismo - Nutrición. La Habana: Editorial Ciencias Médicas; 2018. p. 187-8.

  20. Díaz-MartínezX, PetermannF, LeivaAM, et al. Association of physical inactivity with obesity, diabetes, hypertension and metabolic syndrome in the Chilean population.Rev Med Chil. 2018 May;146(5):585-95. Citado en PubMed; PMID: 30148922.

  21. YangTJ, ChiuCH, TsengMH, et al. The Influence of Pre-Exercise Glucose versus Fructose Ingestion on Subsequent Postprandial Lipemia.Nutrients.2018 Jan 29;10(2).Citado en PubMed; PMID: 29382142.

  22. LitmanEA, GortmakerSL, EbbelingCB, et al. Source of bias in sugar-sweetened beverage research: A systematic review. Public Health Nutr. 2018;21(12):2345-50. Citado en PubMed; PMID: PMID: 29576024.

  23. BraunsteinCR, NoronhaJC, GlennAJ, et al. A double-blind, randomized controlled, acute feeding equivalence trial of small, catalytic doses of fructose and allulose on postprandial blood glucose metabolism in healthy participants: The Fructose and Allulose Catalytic Effects (FACE) Trial. Nutrients.2018;10(6):750. Citado en PubMed; PMID: 29890724.

  24. Geidl-FlueckB, GerberPA. Insights into the Hexose Liver Metabolism-Glucose versus Fructose.Nutrients. 2018;9(9):1026. Citado en PubMed; PMID: 28926951.

  25. PepinA, StanhopeKL, ImbeaultP. Are Fruit Juices Healthier Than Sugar-Sweetened Beverages? A Review.Nutrients. 2019;11(5). Citado en PubMed; PMID: 31052523.

  26. ConnorsP. Dietary Guidelines for Americans 2015-2020. J NutrEduc and Behav [Internet].2016 Jul [citado 24/04/2020];48(7). Disponible en: Disponible en: https://doi.org/10.1016/j.jneb.2016.04.389

  27. RosingerA, HerrickK, GahcheJ, et al. Sugar-sweetened beverage consumption among U.S. youth, 2011-2014.NCHS Data Brief. 2017(271):1-8. Citado en PubMed; PMID: 28135184.

  28. GómezAM. Consumo elevado de fructosa y su posible influencia sobre el metabolismo lipídico. Rev Cubana AlimentNutr [Internet]. 2012[citado 24/04/2020];22(2):287-300. Disponible en: Disponible en: https://www.medigraphic.com/cgi-bin/new/resumen.cgi?IDARTICULO=50835

  29. LeeHJ, ChaJY. Recent insights into the role of ChREBP in intestinal fructose absorption and metabolism.BMB Rep. 2018 Sep;51(9):429-36. Citado en PubMed; PMID: 30158026.

  30. Hannou S, HaslamD, McKeown N, et al.Fructose metabolism and metabolic disease.J Clin Invest. 2018 Feb 1;128(2):545-5. Citado en PubMed; PMID: 29388924.

  31. SiqueiraJH. Sugar-Sweetened Soft Drinks and Fructose Consumption Are Associated with Hyperuricemia: Cross-Sectional Analysis from the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). Nutrients.2018 Jul 27;10(8).Citado in PubMed; PMID: 30060512.

  32. MoulinS, SeematterG, SeysselK. Fructose use in clinical nutrition: Metabolic effects and potential consequences. CurrOpinClinNutrMetab Care.2017;20:272-8.Citado in PubMed; PMID: 28383298.

  33. HerderC, GalaT, Carstensen-KirbergM, et al. Circulating Levels of Interleukin 1-Receptor Antagonist and Risk of Cardiovascular Disease: Meta-Analysis of Six Population-Based Cohorts. ArteriosclerThrombVasc Biol. 2017;37(6):1222-7. Citado in PubMed; PMID:28428221.

  34. NierA, BrandtA, RajcicD, et al. Short-Term Isocaloric Intake of a Fructose-but not Glucose-Rich Diet Affects Bacterial Endotoxin Concentrations and Markers of Metabolic Health in Normal Weight Healthy Subjects. Mol NutrFood Res. 2019 Mar;63(6):e1800868. Citado en PubMed; PMID: 30570214.

  35. Della CorteKW, PerrarI, PenczynskiKJ, et al. Effect of Dietary Sugar Intake on Biomarkers of Subclinical Inflammation: A Systematic Review and Meta-Analysis of Intervention Studies. Nutrients. 2018 May 12;10(5). Citado en PubMed; PMID: 29757229.

  36. TappyL, MorioB, Azzout-MarnicheD, et al. French Recommendations for Sugar Intake in Adults: A Novel Approach Chosen by ANSES. Nutrients. 2018 jul 29;10(8):989. Citado en PubMed; PMID: 30060614.

  37. PahkK, KimEJ, LeeYJ, et al. Characterization of glucose uptake metabolism in visceral fat by 18 F-FDG PET/CT reflects inflammatory status in metabolic syndrome. PLoS One. 2020 Feb 6;15(2):e0228602. Citado en PubMed; PMID: 32027706.

  38. TappyL. Fructose-containing caloric sweeteners as a cause of obesity and metabolic disorders. J Exp Biol. 2018 Mar 7;221. Citado en PubMed; PMID: 29514881.

  39. LeeHA, ChoiEJ, ParkB, et al. The association between metabolic components and markers of inflammatory and endothelial dysfunction in adolescents, based on the Ewha Birth and Growth Cohort Study.PLoSOne. 2020 May 20;15(5):e0233469. Citado en PubMed; PMID: 32433661.

  40. NierA, BrandtA, BaumannA, et al. Metabolic Abnormalities in Normal Weight Children Are Associated with Increased Visceral Fat Accumulation, Elevated Plasma Endotoxin Levels and a Higher Monosaccharide Intake. Nutrients. 2019 Mar 18;1(3). Citado en PubMed; PMID: 30889844.

  41. Martínez-FerránM, de la Guía-GalipiensoF, Sanchis-GomarF, et al. Metabolic Impacts of Confinement during the COVID-19 Pandemic Due to Modified Diet and Physical Activity Habits. Nutrients. 2020 Jun;12(6):1549. Citado en PubMed; PMID: 32466598.

  42. LiuB, LiM, ZhouZ, et al. Can we use interleukin-6 (IL-6) blockade for coronavirus disease (COVID-19)-induced cytokine release syndrome (CRS)? J Autoimmun. 2020;102452. Citado en PubMed; PMID: 32291137.

  43. ValenzuelaPL, MoralesJS, Pareja-GaleanoH, et al. Physical strategies to prevent disuse-induced functional decline in the elderly. Ageing Res Rev. 2018;47:80-8. Citado en PubMed; PMID: 30031068.

  44. SantosFAAD, BackIC, GiehlMWC, et al. Level of leisure-time physical activity and its association with the prevalence of metabolic syndrome in adults: a population-based study. Rev Bras Epidemiol. 2020;23:e200070. Citado en PubMed; PMID: 32638850.

  45. GutholdR, StevensGA, RileyLM, et al. Worldwide trends in insufficient physical activity from 2001 to 2016: A pooled analysis of 358 population-based surveys with 1·9 million participants. Lancet Glob Health. 2018;6(10):e1077-86. Citado en PubMed; PMID: 30193830.

  46. FuL, WangB, YuanT, et al. Clinical characteristics of coronavirus disease; (COVID-19) in China: a systematic review and meta-analysis. J Infect. 2020;80(6): 656-65.Citado en PubMed; PMID: 32283155.

  47. StefanN, BirkenfeldAL, SchulzeMB, et al. Obesity and impaired metabolic health in patients with COVID-19. Nat Rev Endocrinol.2020 Jul;16(7):341-2. Citado en PubMed; PMID: 32327737.




2020     |     www.medigraphic.com